Dual-pathway targeted therapy for Parkinson's disease: Biomimetic nanosomes inhibit ferroptosis and pyroptosis through NLRP3 inflammasome regulation.
帕金森病双通路靶向治疗:仿生纳米体通过 NLRP3 炎症小体调节抑制铁死亡和细胞焦亡
期刊:Bioactive Materials
影响因子:20.3
doi:10.1016/j.bioactmat.2025.06.033
Wang Yi, Liao Xuemei, Guo Qinglong, Zhang Heng, Ye Lei, Yu Liangchen, Kong Xiaoming, Jiang Yicheng, Zhao Peng, Cai Kaiyong, Cheng Hongwei